Abstract
Antimalarial drug discovery has until recently been driven by high-throughput phenotypic cellular screening, allowing millions of compounds to be assayed and delivering clinical drug candidates. In this review, we will focus on target-based approaches, describing recent advances in our understanding of druggable targets in the malaria parasite. Targeting multiple stages of the Plasmodium lifecycle, rather than just the clinically symptomatic asexual blood stage, has become a requirement for new antimalarial medicines, and we link pharmacological data clearly to the parasite stages to which it applies. Finally, we highlight the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY, a web resource developed for the malaria research community that provides open and optimized access to published data on malaria pharmacology.
Original language | English |
---|---|
Pages (from-to) | 1899-1929 |
Number of pages | 31 |
Journal | British Journal of Pharmacology |
Volume | 180 |
Issue number | 15 |
Early online date | 17 May 2023 |
DOIs | |
Publication status | Published - Aug 2023 |
Keywords
- bioinformatics
- database
- drug discovery
- malaria
- molecular target
- Plasmodium
ASJC Scopus subject areas
- Pharmacology